Some kind of investigation - maybe exposure in the media would be needed to get Congress to act on it...but I can imagine no one wants to be the person to chop down even thin reeds of hope until there is some better proven option. As soon as Dr. P's first leronlimab paper is published, *then* it would be much more likely, IMO, that some entity would want to foreground the conflicts of interest in the Panel. Just thinking strategically...